These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14370561)

  • 21. Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates.
    Mokrousov I; Bhanu NV; Suffys PN; Kadival GV; Yap SF; Cho SN; Jordaan AM; Narvskaya O; Singh UB; Gomes HM; Lee H; Kulkarni SP; Lim KC; Khan BK; van Soolingen D; Victor TC; Schouls LM
    J Microbiol Methods; 2004 Jun; 57(3):323-35. PubMed ID: 15134881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid drug resistance detection in Mycobacterium tuberculosis: a review of colourimetric methods.
    Palomino JC; Martin A; Portaels F
    Clin Microbiol Infect; 2007 Aug; 13(8):754-62. PubMed ID: 17378933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR.
    Marín M; García de Viedma D; Ruíz-Serrano MJ; Bouza E
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4293-300. PubMed ID: 15504855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug resistance and fitness in Mycobacterium tuberculosis infection.
    Bottger EC; Pletschette M; Andersson D
    J Infect Dis; 2005 Mar; 191(5):823-4; author reply 824. PubMed ID: 15688309
    [No Abstract]   [Full Text] [Related]  

  • 25. Dual-probe assay for rapid detection of drug-resistant Mycobacterium tuberculosis by real-time PCR.
    Wada T; Maeda S; Tamaru A; Imai S; Hase A; Kobayashi K
    J Clin Microbiol; 2004 Nov; 42(11):5277-85. PubMed ID: 15528726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.
    Cox H; Kebede Y; Allamuratova S; Ismailov G; Davletmuratova Z; Byrnes G; Stone C; Niemann S; Rüsch-Gerdes S; Blok L; Doshetov D
    PLoS Med; 2006 Oct; 3(10):e384. PubMed ID: 17020405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis.
    Palomino JC; Martin A; Von Groll A; Portaels F
    J Microbiol Methods; 2008 Oct; 75(2):161-6. PubMed ID: 18627779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Surveillance of resistance of Mycobacterium tuberculosis to anti-TB drugs in Cuba, 1995-1998].
    Montoro E; Echemendía M; Lemus D; Marrero A; Llanes MJ; Valdivia JA
    Biomedica; 2004 Jun; 24 Supp 1():80-4. PubMed ID: 15495575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of biological microchips in the determination of drug-resistance of Mycobacterium tuberculosis to rifampicin].
    Isakova ZhT; Pak OA; Iusupova EIu; Myrzaliev BB; Chubakov TCh; Goncharova ZA; Tumashova AF; Kozhomkulov MD; Kozhomkulov DK; Alisherov ASh; Friedland J; Aldashev AA
    Probl Tuberk Bolezn Legk; 2005; (8):50-3. PubMed ID: 16209022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN; Barrera L
    Medicina (B Aires); 2007; 67(3):231-7. PubMed ID: 17628909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Possibilities in the field of new anti-tuberculosis drugs].
    MASCHERPA P
    G Ital Chemioter; 1954; 1(3-4):340-65. PubMed ID: 14391648
    [No Abstract]   [Full Text] [Related]  

  • 32. Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: results of a national survey.
    Umubyeyi AN; Rigouts L; Shamputa IC; Fissette K; Elkrim Y; de Rijk PW; Struelens MJ; Portaels F
    J Antimicrob Chemother; 2007 May; 59(5):1031-3. PubMed ID: 17329272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug resistance among Mycobacterium tuberculosis strains in immigrants: is there a real threat everywhere?
    Esteban J; Granizo JJ; Alvarez-Castillo MC; Soriano F
    Clin Microbiol Infect; 2004 Apr; 10(4):335-6. PubMed ID: 15059124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Enhance the research and application of new technique for laboratory diagnosis and drug susceptibility of tuberculosis].
    Hu ZY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Feb; 42(2):75-6. PubMed ID: 18642655
    [No Abstract]   [Full Text] [Related]  

  • 35. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
    Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
    Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Monitoring of chemotherapy in patients with pulmonary tuberculosis by the blood bacteriostatic activity-determining test].
    Manicheva OA; Skvortsova LA; Pavlova MV; Sapozhnikova NV; Archakova LI; Vishnevskiĭ BI
    Probl Tuberk Bolezn Legk; 2008; (5):14-7. PubMed ID: 18711812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].
    Zinov'ev IP; Esaulova NA; Novikov VG; Kokovikhina IA
    Probl Tuberk Bolezn Legk; 2009; (4):37-9. PubMed ID: 19514452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.
    Maus CE; Plikaytis BB; Shinnick TM
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3192-7. PubMed ID: 16048924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in drug-resistant Mycobacterium tuberculosis in New York City, 1991-2003.
    Munsiff SS; Li J; Cook SV; Piatek A; Laraque F; Ebrahimzadeh A; Fujiwara PI
    Clin Infect Dis; 2006 Jun; 42(12):1702-10. PubMed ID: 16705575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing.
    Shi R; Zhang J; Li C; Kazumi Y; Sugawara I
    J Clin Microbiol; 2006 Dec; 44(12):4566-8. PubMed ID: 17035499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.